GSK Share Price Drops Over 6% After US Panel Rejects Key Cancer Drug
Market PerformanceGSK Share Price fell sharply by 6.4% on Friday, July 18The stock was trading at 1,321.26 on the London Stock ExchangeThis drop marks one of the biggest single-day falls for GSK in recent monthsMain News: US Regulatory Panel Rejects BlenrepGSK shares declined after its investigat...
Easy & quick